TETRALYSAL 300 MG CAP GEL DURA CT STR X 28

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1291600220074
  • GGREM 510101704118413
  • Código de barras 7897930761322

O que a fonte publica

Detentor do registro
GALDERMA BRASIL LTDA
Princípios ativos
LIMECICLINA
Embalagem
300 MG CAP GEL DURA CT STR X 28
Regime de dispensação
Tarja Vermelha
Tipo de produto
Novo
Classe terapêutica
J1A - TETRACICLINAS E ASSOCIAÇÕES
Prescrição
Sob prescrição ou restrito

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:510101704118413
{
  "name": "TETRALYSAL 300 MG CAP GEL DURA CT STR X 28",
  "holder": "GALDERMA BRASIL LTDA",
  "stripe": "Tarja Vermelha",
  "barcodes": [
    "7897930761322"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "510101704118413",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "00.317.372/0001-46",
  "priceRegime": "Regulado",
  "productName": "TETRALYSAL",
  "productType": "Novo",
  "hospitalOnly": false,
  "presentation": "300 MG CAP GEL DURA CT STR X 28",
  "sourceStatus": null,
  "supplyRegime": "Tarja Vermelha",
  "factoryPrices": {
    "icms-0": "218.43",
    "icms-12": "248.22",
    "icms-17": "263.17",
    "icms-18": "266.38",
    "icms-19": "269.67",
    "icms-20": "273.04",
    "icms-21": "276.49",
    "icms-22": "280.04",
    "icms-23": "283.68",
    "icms-17.5": "264.76",
    "icms-19.5": "271.34",
    "icms-20.5": "274.75",
    "icms-22.5": "281.85",
    "icms-12-alc": "245.24",
    "icms-17-alc": "260.01",
    "icms-18-alc": "263.18",
    "icms-19-alc": "266.43",
    "icms-20-alc": "269.76",
    "icms-21-alc": "273.18",
    "icms-22-alc": "276.68",
    "icms-23-alc": "280.27",
    "withoutTaxes": "215.81",
    "icms-17.5-alc": "261.59",
    "icms-19.5-alc": "268.09",
    "icms-20.5-alc": "271.46",
    "icms-22.5-alc": "278.46"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "LIMECICLINA",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "301.08",
    "icms-12": "342.15",
    "icms-17": "362.75",
    "icms-18": "367.18",
    "icms-19": "371.71",
    "icms-20": "376.36",
    "icms-21": "381.11",
    "icms-22": "386.01",
    "icms-23": "391.02",
    "icms-17.5": "364.94",
    "icms-19.5": "374.01",
    "icms-20.5": "378.71",
    "icms-22.5": "388.50",
    "icms-12-alc": "339.03",
    "icms-17-alc": "359.45",
    "icms-18-alc": "363.83",
    "icms-19-alc": "368.32",
    "icms-20-alc": "372.93",
    "icms-21-alc": "377.66",
    "icms-22-alc": "382.49",
    "icms-23-alc": "387.46",
    "withoutTaxes": "298.34",
    "icms-17.5-alc": "361.63",
    "icms-19.5-alc": "370.62",
    "icms-20.5-alc": "375.28",
    "icms-22.5-alc": "384.95"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "LIMECICLINA"
  ],
  "therapeuticClass": "J1A - TETRACICLINAS E ASSOCIAÇÕES",
  "commercialisation": {
    "year": 2025,
    "marketed": true
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1291600220074",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "prescription-or-restricted",
  "prescriptionRequired": true,
  "therapeuticClassCode": "J1A",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:510101704118413"